Tag: MCP

Blue Horseshoe Stocks: CYBR, MCP, MEIP & More

CyberArk Software, Ltd. CYBR

Our first experiences with CYBR were good ones, when we successfully called a couple of potentially lucrative options trades around the middle of last month. It was in our report from February 13ththat we targeted CYBR $50 and $55 Calls, and that day we saw moves in those contracts of 72% and 165% respectively.
–
We flagged CYBR once again yesterday, which had previously been under several weeks of consolidation, yet was gapping up in the premarket. The stock did well in reversing its path, trading in a range from 50.79-55.03, and holding the majority of those gains into the close.

Our current options idea is going to be the 04/17 $50 Calls (Closed at 6.60 yesterday). Should CYBR reach its way back to the $60-level anytime in the next few weeks, the gains we see in those contracts will be quite substantial.

Molycorp, Inc. MCP

MCP appeared in yesterday’s extended watchlist and demonstrated a reversal of its own. We’re going to place MCP on more intensive watch as the week progresses, as it has the markings of a potential bottom play.

We’ve illustrated some of the key characteristics of the chart below, which appears to be gearing up for what could be a big swing. The stock ran well over a dollar at the beginning of last month, so the potential for rapid gains has certainly been demonstrated.

MEI Pharma, Inc. MEIP

We’ve also got an eye on MEIP after the stock was crushed down to a 52-week low yesterday, following the company’s announcement of the failure of its cancer drug in middle-stage testing.

A single-session depreciation on the order of 70% is the hallmark of one heck of a knee-jerk reaction, and the stock appears to be gapping up slightly this morning, so we’ll be on the lookout for a recovery in MEIP shares in coming days.

Extended Watchlist:
IMGN, ATOS ISR, HEB, GEVO, NEPT

Blue Horseshoe Stocks: Options Recap, Cyber-Security Watchlist & More

Recapping Friday’s Options Ideas

Nike, Inc. NKE –  On Friday morning, NKE was in the midst of gapping up on the heels of its earnings call, and we came up with daytrading ideas for the $100-104 Weekly Calls. There turned out to be great opportunity in that range as NKE surged to a daily high of 103.79:

$100 Calls – Range:1.38-3.75 – Max Gain: 172%
$101 Calls – Range: .70-2.80 – Max Gain: 300%
$102 Calls – Range: .18-1.75 – Max Gain: 872%
$103 Calls – Range: .10-.85 – Max Gain: 750%

____

Prothena Corp plc PRTA was the other options target we were monitoring on Friday for swing trades.  Specifically, we were looking at the $40 and $45 Calls, and both sets of contracts made big initial moves, followed by pullbacks and additional swings later in the session.

The $35 Calls first shot out of the gate trading at a low of  5.32 and running as high as 9.50 for an initial pop of 78%, before tapering back to 2.40 then recovering to 3.92, for an added 63% move.

The $40’s would open with a 116% spike from 3.00-6.50, followed by a later swing from 2.45-2.90, an extra 18% swing.

Cyber-Security Watchlist

We want to re-radar a couple of cyber security firms that we’ve mentioned in the past, as they have both been on a bit of a downtrend, yet appear to be gapping up this morning.

 CyberArk Software Ltd. CYBR  & FireEye, Inc. FEYE are going to go back on our active watchlist as we kick off a new trading week. Once we’re able to confirm reversals for each of these plays, we can then begin to formulate options strategies accordingly. Stay tuned to our reports this week, and we’ll be sure to have some ideas to pass along.

Extended Watchlist:
IMGN, FRSH, MCP, CAPN, PAL, CANF, AMBS(On Bottom-Watch)

Blue Horseshoe Stocks: PBR Options Update & More

Petroleo Brasiliero S.A. (Petrobras) PBR – Options Update

We called for a potential dip-and-rip play on PBR Calls yesterday, after following the contracts to gains exceeding 200% on Monday-Tuesday’s spike to .64. We did see the dip back down to the .30-range, and the subsequent rip came too, as the $16 Weeklies we’ve tracked from a low of .20 hit the 300% mark at .80 yesterday.

If you recall Tuesday’s report, we said: “Should PBR approach the 16.35-level, we would then have to consider moving up our strike price.”  PBR did indeed test and break that price target (HOD 16.76) during yesterday’s session, and as a result the $16.50 Calls went on a romp from a low of .18 to .46, an impressive single session move of 155%

We hope our meticulous and spot-on forecasting of the PBR Options chain this week has at the very least, illustrated why we like to cover options just as well as stocks. As you can plainly see, the chances for quick gains are plentiful under the right conditions, as evidenced by the exponential profits offered to us by this play, time and time again.

Even as the talking heads saw fit to downgrade PBR earlier this year, we’ve stuck with it as it was coming off of ten-year lows back in March at 11.25, and brought continuous coverage as the stock has bulled its way up to more than $17. This will definitely go down as one of the brightest spots in 2014, a year that has thus far been extremely good to us.

Med-Cannabis Pharma, Inc. MCPI

We mentioned that MCPI might see some momentum carryover from Tuesday’s session in yesterday morning’s report, and that’s just what we saw. The stock would make an intraday move of 25% from .4375-.5475.

.Monday’s initial alert on MCPI gave folks a chance to grab MCPI as low as .355, from which yesterday’s high marked an increase of 54%

It’s also given us a chance to get our feet wet within the slowly-forming Washington State-based cannabis industry. We’ll have our eyes peeled for others that are sure to pop up as the state makes its transition away from prohibition.

Added Note:

World Wrestling Entertainment, Inc. WWE 

Just to throw in a new options trading idea as we approach the end of the week, we’re going to be monitoring the WWE 09/20 $15 Calls, which closed at .50 yesterday.

Extended Watchlist:
HZNP, LIME, MCP, SAAS, SSYS, DDD